RISANKIZUMAB — all Canadian products
7 DINs
6 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is RISANKIZUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02519283 | SKYRIZI | ABBVIE CORPORATION | Solution | Subcutaneous | RISANKIZUMAB 150 MG | Marketed | |
| 02519291 | SKYRIZI | ABBVIE CORPORATION | Solution | Subcutaneous | RISANKIZUMAB 150 MG | Marketed | |
| 02532093 | SKYRIZI | ABBVIE CORPORATION | Solution | Subcutaneous | RISANKIZUMAB 360 MG | Marketed | |
| 02532107 | SKYRIZI | ABBVIE CORPORATION | Solution | Intravenous | RISANKIZUMAB 60 MG | Marketed | |
| 02546922 | SKYRIZI | ABBVIE CORPORATION | Solution | Subcutaneous | RISANKIZUMAB 90 MG | Approved | |
| 02552507 | SKYRIZI | ABBVIE CORPORATION | Solution | Subcutaneous | RISANKIZUMAB 180 MG | Marketed | |
| 02487454 | SKYRIZI | ABBVIE CORPORATION | Solution | Subcutaneous | RISANKIZUMAB 75 MG | Cancelled Post Market |
Browse other molecules: